Tagged as: Lenacapavir

Frontline AIDS welcomes Gilead’s announcement to allow six generic manufacturers to sell its potentially game-changing HIV prevention drug, lenacapa...

This year, researchers unveiled major interim results from two Phase 3 trials of injectable lenacapavir (LEN-LA). This new long-acting injectable, adm...